Menu Search
Equities

Opticept Technologies AB

725:FRA

Opticept Technologies AB

Actions
  • Price (EUR)0.2055
  • Today's Change-0.004 / -1.91%
  • Shares traded8.59k
  • 1 Year change-63.95%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 08:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OptiCept Technologies AB, formerly OptiFreeze AB is a Sweden-based company, which provides the food and plant industry with high-tech solutions that contribute to a more sustainable world and enable climate-smart economic growth. OptiCept optimizes biological processes - Increased extraction from the raw material, extended shelf life, reduced waste, and improved quality (taste, aroma, color, nutritional content) of the final product. Through patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion), the technology opens up new business opportunities for the food and plant propagation industry worldwide. OptiCept's purpose is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and PlantTech.

  • Revenue in SEK (TTM)9.15m
  • Net income in SEK-80.36m
  • Incorporated2011
  • Employees29.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.